Newco news Icosavax gets a $16.5M boost to study its COVID-19 candidate Nov. 2, 2020 By Lee Landenberger No Comments A multimillion dollar windfall for Icosavax Inc. will help allow the company to launch a COVID-19 vaccination program using its virus-like particle candidate (VLP), IVX-411, that displays the SAR-CoV-2 receptor-binding domain.Read More